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Abstract
Background: The neuropeptide calcitonin gene-related peptide (CGRP) has been described to have an inhibitory
effect on endotoxin- and wear particle-induced inflammation in the early stages of periprosthetic osteolysis. In the
present study, the crosstalk between immune cells and osteoblasts in osteolytic conditions treated with CGRP has
been analyzed to evaluate whether the anti-inflammatory properties of the peptide also have a beneficial, i.e. an
anti-resorptive and osteo-anabolic impact on bone metabolism.
Methods: MG-63 osteoblast-like cells were co-cultured with THP-1 macrophage-like cells stimulated with either
ultra-high molecular weight polyethylene (UHMWPE) particles or different concentrations of bacterial lipopolysaccharides
(LPS) and simultaneously treated with CGRP. Inflammation was monitored in terms of measuring the levels of tumor
necrosis factor (TNF)-α secretion. Furthermore, the production of the osteoblast markers osteoprotegerin (OPG), receptor
activator of nuclear factor κB ligand (RANKL), alkaline phosphatase (ALP) and osteopontin (OPN) was quantified. Also, ALP
enzymatic activity was measured.
Results: Stimulation of co-cultured THP-1 macrophages with either high levels of LPS or UHMWPE induced
the secretion of TNF-α which could be inhibited by CGRP to a great extent. However, no remarkable changes
in the OPG/RANKL ratio or bone ALP activity were observed. Interestingly, OPN was exclusively produced by
THP-1 cells, thus acting as a marker of inflammation. In addition, TNF-α production in THP-1 single cell cultures was
found to be considerably higher than in co-cultured cells.
Conclusions: In the co-culture system used in the present study, no obvious relation between inflammation,
its mitigation by CGRP, and the modulation of bone metabolism became evident. Nonetheless, the results
suggest that during the onset of periprosthetic osteolysis the focus might lie on the modulation of inflammatory
reactions. Possibly, implant-related inflammation might merely have an impact on osteoclast differentiation rather
than on the regulation of osteoblast activity.
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Background
Aseptic loosening due to particle-induced osteolysis
remains a major complication associated with total joint
replacement procedures. Thereby, detrimental effects on
bone anchoring the implant are elicited by prosthesis-
derived wear debris consisting of various materials such
as titanium, polyethylene, and ceramics. Amongst these,
ultra-high molecular weight polyethylene (UHMWPE)
particles are thought to play a leading role in the devel-
opment of periprosthetic bone resorption due to their
size and biological activity [1, 2]. Furthermore, both
soluble and adsorbed endotoxins in subclinical concen-
trations are described to play a role in the onset of asep-
tic osteolysis [3, 4]. Both particulate wear debris and
endotoxins interact with immune cells in the peripros-
thetic interface membrane surrounding the implant.
Upon contact with or phagocytosis by the cells—prima-
rily macrophages—an inflammatory response is elicited
which leads to the secretion of a variety of pro-
inflammatory cytokines and chemokines. These in turn
promote the differentiation and activation of bone
resorbing osteoclasts facilitating osteolysis [5].
At the implant interface bone cells such as osteoclasts
and osteoblasts are in close contact to fibroblasts and
macrophages of the synovial membrane [6, 7]. Because
of this spatial proximity a direct interplay between the
immune system and bone seems reasonable. Also, im-
mune cells and bone cells are known to share a number
of signaling molecules which link immunological reac-
tions and skeletal metabolism, a connection also termed
“osteoimmunology” [8].
Interactions between bone cells and macrophages have
been described previously [9]: osteoblasts are able to re-
spond to soluble factors released by macrophages con-
tributing to the modulation of both macrophage and
osteoclast activity. Since we have previously shown an
inhibitory effect of the neuropeptide calcitonin gene-
related peptide (CGRP) on pro-inflammatory cytokine
production by macrophages [10] we wondered whether
this would directly contribute to an alteration of bone
cell biology and bone metabolism. Therefore, we ana-
lyzed the interaction of particle- and LPS-stimulated
macrophages with bone forming osteoblasts in the
present study. The osteoblastic proteins receptor activa-
tor of nuclear factor kappa B ligand (RANKL) and osteo-
protegerin (OPG) are thought to play a key role in the
regulation of bone metabolism whereby the ratio of
these proteins determines the rate of bone resorption
[11]. Therefore, we questioned whether the osteoblastic
production of OPG and RANKL was influenced by pro-
inflammatory macrophages and whether CGRP treat-
ment had an effect on the OPG/RANKL ratio. Moreover,
the osteoblast activity markers alkaline phosphatase
(ALP) and osteopontin (OPN) were analyzed under
inflammatory conditions treated with CGRP. Thus, we
examined whether the neuropeptide CGRP could impli-
citly influence osteoblast activity by modulating the
immune response of macrophages.
Methods
Calcitonin gene-related peptide
Human CGRP (Sigma Aldrich, Saint Louis, Missouri,
USA) was dissolved in dimethyl sulfoxide (DMSO;
Sigma Aldrich, Saint Louis, Missouri, USA), further di-
luted in Dulbecco’s phosphate-buffered saline (DPBS;
Sigma-Aldrich, Saint Louis, Missouri, USA) and stored
at −20 °C until use. During the experiments, THP-1 cells
were treated with a commonly used final concentration
of 10−8 M CGRP often shown to exert maximal effects
in cell culture [10, 12–16] while equal amounts of DPBS
were added to the corresponding controls.
Particles
UHMWPE particles (Ceridust VP3610) with a mean par-
ticle size (given as equivalent circle diameter) of 1.75 ±
1.43 μm (range 0.06–11.06 μm) were provided by
Clariant (Gersthofen, Germany) [17]. For use in cell cul-
ture experiments the particles were cleaned in 99 %
ethanol for 24 h and dried in a desiccator afterwards.
Endotoxin decontamination was confirmed using a lim-
ulus amebocyte lysate (LAL) assay (Charles River, Kent,
United Kingdom) with a sensitivity of 0.25 EU/ml fol-
lowing the manufacturer’s instructions. Subsequently,
the particles were dissolved in sterile 10 % endotoxin-
free bovine serum albumin (BSA; Sigma Aldrich, Saint
Louis, Missouri, USA) in order to achieve good contact
with the cells [18]. Flow cytometry (BD FACSCalibur;
BD Biosciences, Heidelberg, Germany) was used to
determine the number of particles per volume of solu-
tion. For the experiments, UHMWPE particles were
added to THP-1 cells at a cell-to-particle ratio of 1:500
which has previously been shown to exert major effects
in both inflammatory and bone cells [10, 16, 19, 20].
LPS from Escherichia coli 055:B6 (Sigma Aldrich, Saint
Louis, Missouri, USA) was used as a further inducer of
osteolysis-associated inflammation. LPS was reconsti-
tuted in DPBS and stored at −20 °C until use. During
the experiments, LPS was added to the cells at two
different concentrations representing low (10 pg/ml) and
high (100 ng/ml) endotoxin levels [21, 22].
Cells
The acute human monocytic leukemia cell line THP-1
(CLS Cell Lines Service, Eppelheim, Germany) was cul-
tured in RPMI-1640 medium (GE Healthcare, Chalfont
St. Giles, United Kingdom) supplemented with 10 %
fetal calf serum (FCS; GE Healthcare, Chalfont St.
Giles, United Kingdom), 100 U/ml penicillin (Gibco,
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Darmstadt, Germany), 100 μg/ml streptomycin (Gibco,
Darmstadt, Germany) and 2 mM L-glutamine (Gibco,
Darmstadt, Germany) in a humidified environment at
5 % CO2 and 37 °C. For the experiments, the cells were
transferred into 6-well polyethylene terephthalate (PET)
transwell permeable supports with a pore size of 0.4 μm
(Corning, Acton, Massachusetts, USA) at a quantity of ap-
proximately 5.5 × 105 cells per membrane [10]. In order to
enhance phagocytic activity, THP-1 monocytes in suspen-
sion were differentiated into adherent macrophage-like
cells using phorbol-12-myristate-13-acetate (PMA; Cal-
biochem, Darmstadt, Germany), at a final concentration
of 50 nM for 96 h [23–25]. Thereby, the medium was
changed once after an initial 72 h of incubation.
The human osteosarcoma cell line MG-63 (CLS Cell
Lines Service, Eppelheim, Germany) was used as a model
system for osteoblasts [26]. Adherent growing cells were
cultured in DMEM/Ham’s F12 medium (Biochrom,
Berlin, Germany) supplemented with 10 % FCS (GE
Healthcare, Chalfont St. Giles, United Kingdom), 100 U/
ml penicillin (Gibco, Darmstadt, Germany), 100 μg/ml
streptomycin (Gibco, Darmstadt, Germany) and 2 mM L-
glutamine (Gibco, Darmstadt, Germany) in a humidified
environment at 5 % CO2 and 37 °C. For the experiments,
the cells were transferred into 6-well flat-bottomed cell
culture plates (BD Biosciences, Heidelberg, Germany) at a
quantity of approximately 1 × 105 cells per well [16].
Thereby, about 75 % confluence was reached after 24 h of
cell seeding.
Co-culture
THP-1 cells were differentiated in cell culture inserts for
96 h while MG-63 cells were seeded in 6-well cell cul-
ture plates 24 h prior to the experiment and incubated
separately as described above. The cells were washed
once in DPBS before the inserts containing THP-1 cells
were added to the MG-63 cells in order to generate
indirect co-cultures. Inserts without THP-1 cells were
used as an internal control. RPMI containing LPS,
UHMWPE and/or CGRP was added to the inserts
(Table 1) while fresh DMEM/Ham’s F12 medium was
added to MG-63 cells in the wells. Co-culture of macro-
phage- and osteoblast-like cells simulating the environ-
ment surrounding prostheses during the process of
aseptic loosening was performed for 6, 24, and 48 h of
incubation. Cell culture media were collected upon ter-
mination of the experiments at each time point.
Insoluble material was pelleted by centrifugation at
200 × g and 4 °C for 10 min and the supernatants
were stored at −20 °C until further use. Furthermore,
total RNA was extracted from MG-63 cells after 6
and 24 h of incubation while cell lysates for the de-
termination of osteoblastic ALP activity were gener-
ated after 24 and 48 h of incubation.
Cell viability
In order to test for compound-mediated cytotoxicity,
both cell types were separately incubated in 96-well
flat-bottomed cell culture plates (BD Biosciences,
Heidelberg, Germany) together with the various com-
pounds used in the study for up to 48 h. To analyze
for cell-mediated cytotoxicity the cells were co-
cultured in a 96-well HTS transwell tissue culture sys-
tem (Corning, Acton, Massachusetts, USA) for up to 48 h.
Potential cytotoxic effects were determined by measuring
lactate dehydrogenase (LDH) activity in cell culture media
using a commercially available LDH assay kit (Pierce
Table 1 MG-63 osteoblasts co-cultured with THP-1 macrophages under virtually osteolytic conditions treated with CGRP
Incubation time Stimulation Treatment
Negative Control LPS (10 pg/ml) LPS (100 ng/ml) UHMWPE (1:500)
6 h MG-63 Control MG-63 Control MG-63 Control MG-63 Control Control
MG-63 Control MG-63 Control MG-63 Control MG-63 Control CGRP (10−8 M)
MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 Control
MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 CGRP (10−8 M)
24 h MG-63 Control MG-63 Control MG-63 Control MG-63 Control Control
MG-63 Control MG-63 Control MG-63 Control MG-63 Control CGRP (10−8 M)
MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 Control
MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 CGRP (10−8 M)
48 h MG-63 Control MG-63 Control MG-63 Control MG-63 Control Control
MG-63 Control MG-63 Control MG-63 Control MG-63 Control CGRP (10−8 M)
MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 Control
MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 MG-63 + THP-1 CGRP (10−8 M)
THP-1 macrophage-like cells, co-cultured with MG-63 osteoblast-like cells, were subjected to various virtually osteolytic stimuli (negative control, LPS concentrations of
10 pg/ml and 100 ng/ml, and UHMWPE with a cell-to-particle ratio of 1:500) and neuropeptide treatment (control, CGRP) for 6, 24 and 48 h of incubation
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Biotechnology, Rockford, Illinois, USA) according to the
manufacturer’s specifications.
Compound-affected cell viability was reduced by
high levels of LPS and UHMWPE particles as com-
pared to the corresponding negative control at se-
lected time points. However, no remarkable changes
were observed with overall viability ranging between
95–100 % for MG-63 and 94–99 % for THP-1 cells
in comparison to the untreated control (93–100 %
and 98–100 %, respectively). Also, viability was not
considerably decreased in co-culture conditions ran-
ging between 97–100 %.
RNA isolation and quantitative RT-PCR
Total RNA was extracted from co-cultured MG-63
osteoblast-like cells using the NucleoSpin RNA Kit
(Macherey-Nagel, Dueren, Germany) according to the
manufacturer’s instructions and stored at −70 °C until
use. RNA concentration and purity were determined
photometrically using the NanoDrop ND-1000 system
(Peqlab, Erlangen, Germany). Single-stranded cDNA was
synthesized from 500 ng of total RNA at 42 °C for
60 min by reverse transcription using the RevertAid H−
First Strand cDNA synthesis kit (Thermo Fisher Scien-
tific, Waltham, Massachusetts, USA) with oligo(dT)18
primers. Subsequently, 12.5 ng of cDNA were amplified
by quantitative polymerase chain reaction employing the
QuantiTect SYBR Green PCR kit (Qiagen, Hilden,
Germany) following the manufacturer’s instructions.
Amplification of each cDNA sample was performed in
duplicate using QuantiTect Primer assays (Qiagen,
Hilden, Germany) for the detection of mRNA levels of
RANKL (fragment size: 91 bp, Cat. No. QT00215614),
OPG (fragment size: 107 bp, Cat. No. QT00014294),
ALP (fragment size: 110 bp, Cat. No. QT00012957) and
the housekeeping gene glycerine-aldehyde-3-phosphate-
dehydrogenase (GAPDH; fragment size: 95 bp, Cat. No.
QT00079247) using an AB7500 Real-Time PCR Cycler
(Applied Biosystems, Darmstadt, Germany). A total
number of 45 cycles was performed. For each pair of
primers a negative control reaction without cDNA (no
template control) was included. To further control for re-
sidual genomic DNA contamination, amplification was
also performed on samples without reverse transcriptase
(no reverse transcription control). The levels of expression
of each sample were normalized to the expression of the
housekeeping gene GAPDH. Results were calculated using
the comparative method of relative quantification [27].
ELISA
Levels of the pro-inflammatory cytokine human TNF-α as
well as the osteoblast specific protein secretion of human
RANKL, OPG and OPN were quantified in cell culture
supernatants using a commercially available enzyme-linked
immunosorbent assay (ELISA) kit (R&D Systems,
Minneapolis, Minnesota, USA) following the manufac-
turer’s instructions. All samples were measured in duplicate
using the ELx808 microplate reader (BioTek Instruments,
Winooski, Vermont, USA) for data acquisition. Protein
concentrations were calculated from the appropriate stand-
ard curves using the MikroWin 2000 software (Mikrotek
Laboratory Systems, Overath, Germany).
Western blot
MG-63 cells in single cell or co-culture stimulated with
either UHMWPE particles or LPS and treated with CGRP
for 6–48 h of incubation were collected as described
above and total protein was extracted using radioimmuno-
precipitation assay (RIPA) buffer (Thermo Fisher Scien-
tific, Waltham, Massachusetts, USA). The cells were lysed
for 30 min on ice, sonicated for 30 s at 50 % amplitude
using an ultrasonic processor (Type UP100H; Hielscher
Ultrasonics, Teltow, Germany) and centrifuged at 13.000 ×
g for 15 min at 4 °C. The supernatant was recovered and
stored at −20 °C until further analysis. Total protein
content of the cell lysates was quantified using the
Pierce BCA assay kit (Thermo Fisher Scientific,
Waltham, Massachusetts, USA) according to the man-
ufacturer’s protocol for the microplate procedure.
Equal amounts of protein (20 μg) along with recom-
binant human soluble (s)RANKL (100 ng; PeproTech,
Hamburg, Germany) and LNCaP whole cell lysate
(25 μg, sc-2231; Santa Cruz Biotechnology, Dallas, Texas,
USA) were separated by 8–16 % tris-glycine SDS-PAGE
(Thermo Fisher Scientific, Waltham, Massachusetts, USA)
and then electro-blotted to 0.45 μm nitrocellulose mem-
branes (Bio-Rad, Hercules, California, USA). Following
protein transfer, the membranes were blocked with 3 %
BSA in PBS containing 0.05 % Tween-20 for 1 h at room
temperature before incubation with a rabbit polyclonal
anti-human full-length (fl)RANKL antibody (sc-9073, final
dilution 1: 200; Santa Cruz Biotechnology, Dallas, Texas,
USA) or a rabbit polyclonal anti-human sRANKL antibody
(500-P133, final dilution 1:500; PeproTech, Hamburg,
Germany) overnight at 4 °C. GAPDH (sc-25778, final
dilution 1:1000; Santa Cruz Biotechnology, Dallas,
Texas, USA) was used as an internal control. Specific-
ally bound primary antibodies were detected with
peroxidase-conjugated secondary antibodies. Protein
bands were detected by enhanced chemiluminescence
(Pierce ECL Western Blotting Substrate; Thermo
Fisher Scientific, Waltham, Massachusetts, USA) and
visualized by conventional film-based imaging (GE
Healthcare, Chalfont St. Giles, UK).
ALP activity
Osteoblast specific ALP activity was measured using a
colorimetric Alkaline Phosphatase Assay Kit (abcam,
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Milton, England) according to the manufacturer’s
instructions. Upon termination of the experiment MG-
63 cells were detached from the cell culture plate,
collected at 1000 × g and 4 °C for 5 min and resus-
pended in 230 μl (24 h) or 350 μl (48 h) of ALP assay
buffer. Lysis was performed by five repeated freeze/thaw
cycles in liquid nitrogen at −196 °C and a water bath at
37 °C respectively. Cell lysates were stored at −20 °C
until use. Prior to measuring the ALP activity of the cell
lysates insoluble material was removed by centrifugation
at 13.000 × g and 4 °C for 3 min. Aliquots of 80 μl of
the supernatants were subjected to analysis in duplicate.
The conversion of para-nitrophenylphosphate (pNPP)
chromogenic substrate over 60 min was compared to a
standard curve as specified by the manufacturer.
Statistics
All data are expressed as mean ± standard deviation
derived from at least three independent experiments.
Statistical analysis was carried out using GraphPad
Prism 6 (GraphPad, La Jolla, California, USA). One-
way analysis of variance (ANOVA) followed by Tukey
post hoc analysis was performed to evaluate differ-
ences within and between the experimental groups.
Statistical significance was considered at p < 0.05 (*).
Results were further considered to be very statistically
significant (**) at p < 0.01 and extremely statistically
significant (***) at p < 0.001.
Results
Both UHMWPE particles and LPS provoke an
inflammatory reaction in THP-1 macrophage-like cells
TNF-α secretion upon stimulation of the cells with
either UHMWPE particles or LPS could only be de-
tected in co-cultures as compared to osteoblastic cells
alone (Fig. 1). This suggested THP-1 macrophages to be
the exclusive source of the pro-inflammatory cytokine.
As expected, high levels of LPS always induced the
strongest cellular response (p < 0.001 at 6 h) with
TNF-α levels decreasing over time (data for other
time points not shown) while UHMWPE induced
only minor changes (n.s.) as compared to the control.
However, no TNF-α production could be measured
using low levels of LPS. Since no pro-inflammatory
response which could have further influenced osteo-
blastic cells in co-culture was evoked by 10 pg/ml of
LPS, hereafter only results for high levels of LPS
(100 ng/ml) are shown.
In THP-1 cells cultured alone TNF-α was induced by
both high LPS concentrations (Fig. 1a) and UHMWPE
(Fig. 1b) as described above. Interestingly, secreted TNF-
α was much higher at all time points (p < 0.001 at 6 h,
data for other time points not shown) when compared
to cells co-cultured with osteoblasts suggesting that the
presence of osteoblastic cells might reduce the inflam-
matory reaction of THP-1 macrophages in terms of
TNF-α production.
CGRP modulates the inflammatory reaction of THP-1
macrophage-like cells towards wear particles and
lipopolysaccharides
Both LPS- and particle-induced levels of TNF-α were
temporarily inhibited by application of the neuropeptide
CGRP in co-cultures of THP-1 and MG-63 cells (Fig. 2).
TNF-α secretion as induced by high levels of LPS was
mitigated by CGRP at 6 (p < 0.01, Fig. 2a) and 24 h
(p < 0.05, Fig. 2b) of incubation whereas UHMWPE-
induced TNF-α was suppressed at 6 h (p < 0.001,
Fig. 2c) of incubation only (Fig. 2c-d).
Fig. 1 UHMWPE particle- and LPS-induced TNF-α secretion in THP-1 macrophages co-cultured with MG-63 osteoblasts. THP-1 macrophage-like
cells co-cultured with MG-63 osteoblasts were stimulated with LPS or UHMWPE particles. The secretion of the pro-inflammatory cytokine TNF-α
was quantified in cell culture supernatants. TNF-α secretion [pg/ml] by both co-cultures and controls as per 100.000 cells at 6 h of incubation is
exemplarily shown. Absolute TNF-α cytokine levels secreted by activated co-cultures, THP-1 macrophages and MG-63 osteoblasts at 6 h of incubation
is illustrated for stimulation with a high levels of LPS (100 ng/ml) and b UHMWPE particles (cell-to-particle ratio of 1:500). ***p < 0.001
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OPG is exclusively produced by osteoblast-like cells
The osteoblast specific protein OPG was secreted to a
high degree by MG-63 cells exclusively (1126.189 ±
103.301–14491.261 ± 1305.334 pg/ml per 10 μg of total
protein in co-cultures and 1035.728 ± 155.053–11.086.096
± 1536.920 pg/ml per 10 μg of total protein in MG-63
controls while OPG levels in THP-1 single cell cultures
where below the detection limit). Secreted OPG levels in
osteoblast-like control cultures decreased upon stimu-
lation with both LPS (p < 0.05) and UHMWPE particles
(p < 0.01) whereby significant effects were primarily ob-
served at 6 h of incubation. In contrast, no changes (n.s.)
could be observed in co-cultures with THP-1 cells
(Fig. 3a-b). The data suggest that, under conditions similar
to those in the human body, the focus in the onset of oste-
olysis might lie on inflammatory reactions rather than on
changes in bone metabolism in the first place.
Remarkably, CGRP could reverse the inhibitory impact
of LPS and UHMWPE particles on OPG secretion.
However, on the protein level this was observed in MG-
63 control cultures only. Thereby, both LPS- (p < 0.05,
Fig. 4a) and particle- (p < 0.01, Fig. 4b) obstructed OPG
levels were enhanced by CGRP treatment at 6 h of incu-
bation (Fig. 4, data for other time points not shown). In
contrast, only minor and partially adverse effects could
be observed in co-cultured cells (n.s.).
OPN serves as a marker of inflammation rather than of
bone mineralization
OPN secretion could only be measured in co-culture
supernatants, suggesting its production by THP-1 cells.
Indeed, follow up experiments proved that these cells
are the exclusive source of OPN in the present experi-
mental setup (Fig. 3d, 6 h, data for other time points not
shown). The expression in THP-1 cells cultured alone
was not statistically different from co-cultures.
Stimulation of the co-cultured cells with either LPS or
UHMWPE particles mostly did not induce significant
Fig. 2 CGRP temporarily inhibits particle- and LPS-induced TNF-α secretion in co-cultured THP-1 macrophages. THP-1 macrophage-like cells
co-cultured with MG-63 osteoblasts were stimulated with LPS or UHMWPE particles. The effects of CGRP (10−8 M) treatment on co-cultured cells
were analyzed. Absolute TNF-α secretion [pg/ml] of co-cultures and controls as per 100.000 cells, activated by high levels of LPS (100 ng/ml) for
a 6 h and b 24 h of incubation or activated by UHMWPE (cell-to-particle ratio of 1:500) for c 6 h and d 24 h of incubation as compared to the
respective TNF-α secretion of activated cells treated with the neuropeptide CGRP. *p < 0.05; **p < 0.01; ***p < 0.001
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changes in OPN secretion as compared to the control
(6 h, Fig. 3c). However, overall OPN production in-
creased with advancing incubation times (data for other
time points not shown). All in all OPN was produced in
patterns roughly similar to TNF-α indicating that it
might rather be a marker of inflammation than of bone
cell activity and mineralization.
Intriguingly, CGRP treatment could reduce OPN
levels as induced by stimulation with high levels of
LPS at 6 (p < 0.05, Fig. 5a) and 24 h (p = 0.001, Fig. 5b)
of incubation. Upon stimulation with UHMWPE (6 h,
Fig. 5c) diverse effects could be observed. However, in
case of an alleviation of OPN production (6 h) the
action of CGRP was not significant (data for other
time points not shown).
MG-63 osteoblastic cells do not produce soluble RANKL
during inflammatory reactions
Very low mRNA levels of RANKL were measured
indicating nearly no expression of the gene (data not
shown). Accordingly, no detectable levels of soluble
(s)RANKL were produced by either co-cultures or
MG-63 osteoblastic cells alone upon stimulation with
UHMWPE particles or LPS. In contrast, membrane
bound full-length (fl)RANKL was detectable in ly-
sates of activated MG-63 cells using western blotting
technique (Fig. 6, data shown for 6 and 24 h of incu-
bation). However, neither stimulation of the cells
with UHMWPE and LPS nor treatment with CGRP
could induce changes in the expression of the
protein.
Fig. 3 In MG-63 / THP-1 co-cultures OPG, in contrast to OPN, is secreted by osteoblastic cells. THP-1 macrophage-like cells co-cultured with MG-
63 osteoblasts were stimulated with LPS (100 ng/ml) or UHMWPE particles (cell-to-particle ratio of 1:500). The secretion of the osteoblastic marker
OPG and the multifunctional protein OPN were quantified in cell culture supernatants. OPG secretion [pg/ml] by both co-cultures and controls
as per 10 μg of total MG-63 osteoblast-derived protein at 6 h (a) and b 24 h of incubation is shown. c OPN secretion [pg/ml] by both co-cultures
and controls as per 100.000 cells at 6 h of incubation is exemplarily shown. d OPN secretion, as normalized to the unstimulated control, of MG-63
cells, THP-1 cells and the respective co-cultures activated by LPS (100 ng/ml) or UHMWPE (cell-to-particle ratio of 1:500) is exemplarily shown for
6 h of incubation. THP-1 cells are the source of the protein in the current setup. *p < 0.05; **p < 0.01
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ALP activity is hardly influenced by osteolytic conditions
and their treatment with CGRP
Bone specific ALP expression levels were hardly affected
by stimulation with either LPS or UHMWPE particles
(Fig. 7a). Therefore, application of CGRP did not have
major effects on the expression of ALP (data not shown).
Correspondingly, ALP activity in MG-63 cell lysates
was rather low ranging between 0.00009 and 0.00018 U/
ml per 10 μg of total protein (Fig. 7b). Conversion of
pNPP hardly changed upon stimulation of co-cultures or
controls with either LPS or UHMWPE (n.s.). Application
of CGRP also did not induce relevant changes of ALP
activity (n.s., data not shown).
Discussion
To the best of our knowledge this is the first report
analyzing the influence of the neuropeptide CGRP on
co-cultured osteoblasts and macrophages. The present
study analyzed whether the previously described anti-
inflammatory impact of CGRP on wear particle- and
LPS-induced cytokine secretion [10] would have a
favorable effect on bone metabolism. It is well known
that macrophages play a key role in the regulation of
bone remodeling and homeostasis, mainly by secret-
ing cytokines [28]. Thereby, macrophages do not only
regulate osteoclast activity and contribute to bone
resorption but they also control osteoblast mineralization
Fig. 4 CGRP temporarily augments particle- and LPS-induced OPG secretion in MG-63 osteoblasts cultured alone. THP-1 macrophage-like cells
co-cultured with MG-63 osteoblasts were stimulated with LPS or UHMWPE particles. The effects of CGRP (10−8 M) treatment on co-cultured cells
were analyzed. OPG secretion, as normalized to the unstimulated control, of co-cultures and controls activated by a high levels of LPS
(100 ng/ml) or b UHMWPE (cell-to-particle ratio of 1:500) for 6 h of incubation as compared to the respective OPG fold secretion of
activated cells treated with the neuropeptide CGRP. *p < 0.05; **p < 0.01
Fig. 5 CGRP inhibits THP-1 mediated OPN secretion as elicited by high levels of LPS only. THP-1 macrophage-like cells co-cultured with MG-63
osteoblasts were stimulated with LPS or UHMWPE particles. The effects of CGRP (10−8 M) treatment on co-cultured cells were analyzed. OPN
secretion, as normalized to the unstimulated control, of co-cultures and controls activated by high levels of LPS (100 ng/ml) for a 6 h and b 24 h
of incubation or activated by c UHMWPE (cell-to-particle ratio of 1:500) for 6 h of incubation as compared to the respective OPN fold secretion
of activated cells treated with the neuropeptide CGRP. *p < 0.05; **p < 0.01; ***p < 0.001
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[29–32]. Thus, we questioned whether the inhibition
of the production of pro-inflammatory cytokines by
macrophage-like cells upon CGRP treatment would have
an influence on markers of bone mineralization such as
ALP and OPN or on the production of the osteoblastic
proteins OPG and RANKL.
As described earlier for THP-1 macrophages cultured
alone [10], also in cells co-cultured with MG-63 osteo-
blasts both particle- and LPS-induced TNF-α secretion
was temporarily inhibited upon treatment with CGRP.
Interestingly, in co-cultures TNF-α was secreted to a
lesser extent than in macrophage-like cells alone. This
Fig. 6 RANKL protein expression in particle- and LPS-stimulated MG-63 osteoblasts remains unchanged even upon CGRP treatment. MG-63
osteoblasts were stimulated with LPS (100 ng/ml) or UHMWPE particles (cell-to-particle ratio of 1:500) and treated with CGRP (10−8 M).
Changes in the expression of both full-length (fl) and soluble (s)RANKL protein were assessed by SDS-PAGE and Western Blot. RANKL
protein expression as compared to commercially available LNCaP lysate and recombinant sRANKL as external controls and GAPDH as an
internal control is exemplarily shown for cells at 6 and 24 h of incubation. The sRANKL band provided a very strong signal even upon
low exposition times so that artifacts can be seen in the neighboring lanes
Fig. 7 ALP expression and activity are marginally influenced by UHMWPE particles and LPS in co-cultured osteoblasts. THP-1 macrophage-like
cells co-cultured with MG-63 osteoblasts were stimulated with LPS (100 ng/ml) or UHMWPE particles (cell-to-particle ratio of 1:500). a Relative ALP
mRNA expression by both co-cultures and controls as compared to the housekeeping gene GAPDH at 24 h of incubation is exemplarily shown.
b ALP activity [U/ml] in both co-cultures and controls as per 10 μg of total protein at 24 h of incubation is exemplarily shown
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suggests that the presence of osteoblasts in the co-
culture system might regulate macrophage behavior
upon stimulation with either UHMWPE particles or
LPS. This would concur with earlier studies reporting on
a modulation of the macrophage response by osteoblasts
[33]. Indeed, osteoblasts might be able to inhibit primary
inflammatory reactions, particularly in response to wear
debris, since decreased levels of pro-inflammatory cyto-
kines have been observed in co-culture systems [28, 34].
This anti-inflammatory effect is supposed to be poten-
tially mediated by macrophage-derived prostaglandin E2
(PGE2) or endogenously produced lipoxin [34, 35].
However, not only macrophage behavior is altered.
Previous studies have also shown that macrophage-like
cells are able to influence osteoblast behavior in co-
culture. For instance, the number, activity, and adhesion
of osteoblasts have been described to be decreased in
the presence of macrophages [28, 36]. Furthermore,
macrophages have been shown to enhance the osteoblast
response to wear debris, e.g. with respect to the produc-
tion of pro-inflammatory cytokines such as IL-6 or GM-
CSF [34]. On the other hand, it has been found that
monocytes and macrophages are capable of producing
the osteoinductive protein bone morphogenetic protein
(BMP)-2 which exerts an anabolic effect on osteoblast
differentiation and proliferation [30]. However, such
osteogenic properties could not be confirmed in the
present study since ALP levels as a marker of bone cell
activity and mineralization remained unchanged during
inflammatory reactions and even upon their treatment
with CGRP.
Intriguingly, OPN which has originally been described
to be produced by osteoblasts and their precursors and
to play an important role in the mineralization and
resorption of bone [37–40] was found to be produced in
patterns similar to TNF-α in the present study. Although
protein levels were not distinctly upregulated upon cel-
lular stimulation, this suggests that in the present study
OPN might serve as an indicator of inflammation rather
than as a mineralization marker. Indeed, OPN has been
described as a rather late differentiation marker previ-
ously [41]. Additionally, increased OPN concentrations
have been found to be associated with sites of monocyte
or macrophage accumulation indicating these cells to be
the source of the protein [42]. Actually, we could prove
this to be the case by identifying THP-1 cells as the pro-
ducers of secreted OPN in the setup used here.
Although OPN could already be detected in unstimulated
cells, which might be a side effect of PMA treatment [43],
it even temporarily increased upon stimulation with either
LPS or wear particles. This observation is in line with
other reports revealing OPN to be involved in inflamma-
tion, macrophage recruitment and bone resorption
whereby it is particularly produced in response to
inflammatory stimuli and pro-inflammatory cytokines
[44, 45]. Possibly, OPN and pro-inflammatory cyto-
kines might even stimulate each other’s production to
eventually trigger chronic inflammation. This in turn
indicates a central role for OPN in osteoclast activa-
tion and in wear debris-induced osteolysis [46].
However, it has been shown that the production of the
osteoblast-specific proteins OPG and RANKL was not
strongly influenced by an inflammatory environment
created by THP-1 macrophages. In contrast, the expres-
sion of both RANKL and OPG has been described to be
dramatically affected by LPS or UHMWPE upon direct
contact in osteoblasts cultured alone [16, 20]. Although
our data revealed a temporary decrease of OPG in osteo-
blastic cells upon indirect contact with both LPS and
UHMWPE, RANKL production, unlike previously re-
ported, was not changed following cellular stimulation.
This observation rather matches previous reports reveal-
ing no change in RANKL and OPG levels in co-cultures
of osteoblasts and macrophages exposed to wear parti-
cles [33]. Also, the application of CGRP had only little
effect on the OPG/RANKL ratio. In fact, OPG protein
levels were merely temporarily upregulated upon treat-
ment with CGRP while RANKL production remained
unchanged which eventually might have a slightly bene-
ficial impact on net bone mass.
Taken together, the results of the present study suggest
that in the early stages of periprosthetic osteolysis regula-
tion of inflammation rather than a modulation of bone
metabolism is the center of disease pathology. Also, a neg-
ligible impact of inflammatory reactions on osteoblast
biology is suggested: potentially, the modulation of pri-
mary inflammatory reactions to both wear particles and
endotoxins might have a stronger impact on osteoclasto-
genesis instead. As pro-inflammatory cytokines, especially
TNF-α, already have been reported to have a strong im-
pact on osteoclast differentiation [47, 48] this should be
investigated in appropriate culture systems in the future.
Due to the use of immortalized cell lines the present
study is subject to certain limitations. For instance, the un-
expected lack of OPN production in MG-63 cells is not
observed with primary human osteoblasts (preliminary
data, 262.483 ± 9.079–1948.312 ± 20.885 pg/ml depending
on time and stimulation). Furthermore, co-culture was
performed in a transwell system avoiding cell-to-cell con-
tact. However, a direct contact might be required to be
able to detect physiological changes since differences be-
tween co-cultures in direct as compared to indirect con-
tact have been observed previously [49]. Unfortunately,
due to the differentiation process required for THP-1
macrophages direct co-culture of the cells would seem
quite difficult. Even if the THP-1 cells were seeded in the
lower compartment, MG-63 cells could only be added
after withdrawal of PMA in order to avoid any potential
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adverse effects on the system. Then again, the previously
described spontaneous dedifferentiation of THP-1 macro-
phages during PMA-withdrawal [50] might limit the dur-
ation of experimental observation in this co-culture
system. Therefore, to allow for longer-term observations,
co-cultures employing primary osteoblasts and monocyte-
derived macrophages should be used and are currently be-
ing established. Also, these cells more closely resemble
tissue-residing cells in the periprosthetic environment.
Additionally, the present report lacks a full analysis of the
influence of the impact of macrophages on bone metabol-
ism since osteoclasts have not been examined. In the
future, culture systems employing specific antibodies
against key cytokines involved in periprosthetic osteolysis
or co-cultures of macrophages and osteoclast precursors
should be used to gain an insight into the impact of wear
particle- and endotoxin- mediated inflammation on osteo-
clast differentiation. Thus, a more detailed understanding
of the connection and putative causality between inflam-
mation and bone metabolism can be achieved.
Conclusions
In the present study, the crosstalk between macrophage-
like cells and osteoblastic cells under simulated osteolytic
conditions and their treatment with CGRP was analyzed to
find out whether the anti-inflammatory properties of the
neuropeptide also have a beneficial impact on bone metab-
olism in terms of osteoblast biology. Although TNF-α se-
cretion by co-cultured cells could be inhibited by CGRP,
no remarkable and consistent changes in the OPG/RANKL
ratio or bone ALP activity were observed. Interestingly,
OPN was found to be exclusively produced by THP-1 mac-
rophages serving as an indicator of inflammation. This sug-
gests that in the initial course of periprosthetic osteolysis
focus is on the regulation of inflammation rather than on
the modulation of bone metabolism. Nonetheless, a regula-
tory impact of osteoblasts on macrophages could be
confirmed given an attenuated production of TNF-α in co-
cultured cells as compared to THP-1 macrophages alone.
Availability of data and materials
The datasets supporting the conclusions of this article
are included within the article and its additional files
(Additional files 1, 2 and 3).
Additional files
Additional file 1: Data and statistical analysis of particle- or LPS-
activated THP-1/MG-63 co-cultures. (XLSX 20 kb)
Additional file 2: Data and statistical analysis of particle- or LPS-
activated THP-1/MG-63 co-cultures treated with the neuropeptide CGRP.
(XLSX 19 kb)
Additional file 3: Data and statistical analysis of various particle- or
LPS-activated cell cultures. (XLSX 16 kb)
Abbreviations
ALP: alkaline phosphatase; CGRP: calcitonin gene-related peptide;
flRANKL: full-length RANKL; LPS: lipopolysaccharide; OPG: osteoprotegerin;
OPN: osteopontin; RANKL: receptor activator of nuclear factor kappa B ligand;
sRANKL: soluble RANKL; TNF: tumor necrosis factor; UHMWPE: ultra-high
molecular weight polyethylene.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HJ conceived of the study, participated in its design and coordination,
performed the statistical analysis and drafted the manuscript. HR participated
in the design of the study and performed the experiments. MJ participated
in the statistical analysis and helped to draft the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
The authors thank Dr. Ruediger Schlepper for editorial assistance and proof
reading. They thankfully appreciate the supply of UHMWPE particles by
PD Dr. Christian Wedemeyer (St. Barbara Hospital Gladbeck) and PD
Dr. Max Daniel Kauther (Department of Orthopedic and Trauma Surgery,
University Hospital Essen). They would further like to thank the Institute
of Pharmacogenetics (Prof. Dr. Winfried Siffert), the Research Group
for Molecular Neurosurgery (PD Dr. Yuan Zhu) and the Institute of
Pharmacology (Prof. Dr. Dobromir Dobrev) based at the University
Hospital Essen for the access to some of their laboratory equipment.
Received: 12 December 2015 Accepted: 20 April 2016
References
1. Green TR, Fisher J, Stone M, Wroblewski BM, Ingham E. Polyethylene
particles of a ‘critical size’ are necessary for the induction of cytokines by
macrophages in vitro. Biomaterials. 1998;19(24):2297–302.
2. Willert HG, Bertram H, Buchhorn GH. Osteolysis in alloarthroplasty of the hip.
The role of ultra-high molecular weight polyethylene wear particles. Clin
Orthop Relat Res. 1990;258:95–107.
3. Schaumburger J, Winkler S, Handel M, Grifka J, Baier C. [Prosthesis
loosening]. Z Rheumatol. 2012;71(9):785–97.
4. Lieder R, Petersen PH, Sigurjonsson OE. Endotoxins-the Invisible Companion
in Biomaterials Research. Tissue Eng Part B Rev. 2013;19(5):391–402.
5. Hallab NJ, Jacobs JJ. Biologic effects of implant debris. Bulletin NYU hosp
JT Dis. 2009;67(2):182–8.
6. Horowitz SM, Rapuano BP, Lane JM, Burstein AH. The interaction of the
macrophage and the osteoblast in the pathophysiology of aseptic
loosening of joint replacements. Calcif Tissue Int. 1994;54(4):320–4.
7. Lind M, Trindade MC, Yaszay B, Goodman SB, Smith RL. Effects of particulate
debris on macrophage-dependent fibroblast stimulation in coculture.
J Bone Joint Surg Br. 1998;80(5):924–30.
8. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y.
Osteoimmunology: interplay between the immune system and bone
metabolism. Annu Rev Immunol. 2006;24:33–63.
9. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL,
TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine
Growth Factor Rev. 2004;15(1):49–60.
10. Jablonski H, Kauther MD, Bachmann HS, Jager M, Wedemeyer C. Calcitonin
Gene-Related Peptide Modulates the Production of Pro-Inflammatory
Cytokines Associated with Periprosthetic Osteolysis by THP-1 Macrophage-
Like Cells. Neuroimmunomodulation. 2015;22(3):152–65.
11. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;
142(12):5050–5.
12. Villa I, Mrak E, Rubinacci A, Ravasi F, Guidobono F. CGRP inhibits
osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-
dependent pathway. Am J Physiol Cell Physiol. 2006;291(3):C529–37.
13. Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR. Effects of
calcitonin, amylin, and calcitonin gene-related peptide on osteoclast
development. Bone. 2001;29(2):162–8.
14. Villa I, Melzi R, Pagani F, Ravasi F, Rubinacci A, Guidobono F. Effects of
calcitonin gene-related peptide and amylin on human osteoblast-like cells
proliferation. Eur J Pharmacol. 2000;409(3):273–8.
Jablonski et al. BMC Musculoskeletal Disorders  (2016) 17:199 Page 11 of 12
15. Mrak E, Guidobono F, Moro G, Fraschini G, Rubinacci A, Villa I. Calcitonin
gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by
beta-catenin stabilization. J Cell Physiol. 2010;225(3):701–8.
16. Xu J, Kauther MD, Hartl J, Wedemeyer C. Effects of alpha-calcitonin
gene-related peptide on osteoprotegerin and receptor activator of
nuclear factor-kappaB ligand expression in MG-63 osteoblast-like cells
exposed to polyethylene particles. J Orthop Surg Res. 2010;5:83.
17. von Knoch M, Sprecher C, Barden B, Saxler G, Loer F, Wimmer M. [Size and
shape of commercially available polyethylene particles for in-vitro and
in-vivo-experiments]. Z Orthop Ihre Grenzgeb. 2004;142(3):366–70.
18. Smith RA, Hallab NJ. In vitro macrophage response to polyethylene and
polycarbonate-urethane particles. J Biomed Mater Res A. 2010;93(1):347–55.
19. Baumann B, Rader CP, Seufert J, Noth U, Rolf O, Eulert J, Jakob F. Effects of
polyethylene and TiAlV wear particles on expression of RANK, RANKL and
OPG mRNA. Acta Orthop Scand. 2004;75(3):295–302.
20. Kauther MD, Xu J, Wedemeyer C. Alpha-calcitonin gene-related peptide can
reverse the catabolic influence of UHMWPE particles on RANKL expression
in primary human osteoblasts. Int J Biol Sci. 2010;6(6):525–36.
21. Blomkalns AL, Stoll LL, Shaheen W, Romig-Martin SA, Dickson EW,
Weintraub NL, Denning GM . Low level bacterial endotoxin activates two
distinct signaling pathways in human peripheral blood mononuclear cells.
J Inflamm (London, England). 2011;8:4.
22. Wiesner P, Choi SH, Almazan F, Benner C, Huang W, Diehl CJ, Gonen A,
Butler S, Witztum JL, Glass CK et al. Low doses of lipopolysaccharide and
minimally oxidized low-density lipoprotein cooperatively activate
macrophages via nuclear factor kappa B and activator protein-1: possible
mechanism for acceleration of atherosclerosis by subclinical endotoxemia.
Circ Res. 2010;107(1):56–65.
23. Kubosaki A, Tomaru Y, Tagami M, Arner E, Miura H, Suzuki T, Suzuki M,
Suzuki H, Hayashizaki Y. Genome-wide investigation of in vivo EGR-1
binding sites in monocytic differentiation. Genome Biol. 2009;10(4):R41.
24. Fraser J, Rousseau M, Shenker S, Ferraiuolo MA, Hayashizaki Y, Blanchette M,
Dostie J. Chromatin conformation signatures of cellular differentiation.
Genome Biol. 2009;10(4):R37.
25. Von Eckardstein A, Langer C, Engel T, Schaukal I, Cignarella A, Reinhardt J,
Lorkowski S, Li Z, Zhou X, Cullen P et al. ATP binding cassette transporter
ABCA1 modulates the secretion of apolipoprotein E from human
monocyte-derived macrophages. FASEB J. 2001;15(9):1555–61.
26. Clover J, Gowen M. Are MG-63 and HOS TE85 human osteosarcoma cell
lines representative models of the osteoblastic phenotype? Bone. 1994;
15(6):585–91.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods.
2001;25(4):402–8.
28. Naskar D, Nayak S, Dey T, Kundu SC. Non-mulberry silk fibroin influence
osteogenesis and osteoblast-macrophage cross talk on titanium based
surface. Sci Rep. 2014;4:4745.
29. Lassus J, Salo J, Jiranek WA, Santavirta S, Nevalainen J, Matucci-Cerinic M,
Horak P, Konttinen Y. Macrophage activation results in bone resorption.
Clin Orthop Relat Res. 1998;352:7–15.
30. Pirraco RP, Reis RL, Marques AP. Effect of monocytes/macrophages on the
early osteogenic differentiation of hBMSCs. J Tissue Eng Regen Med. 2013;
7(5):392–400.
31. Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone
remodeling. J Biol Chem. 2010;285(33):25103–8.
32. Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K,
Maylin ER, Ripoll VM, Hume DA, Pettit AR. Osteal tissue macrophages are
intercalated throughout human and mouse bone lining tissues and
regulate osteoblast function in vitro and in vivo. J Immunol. 2008;181(2):
1232–44.
33. Valles G, Gil-Garay E, Munuera L, Vilaboa N. Modulation of the cross-talk
between macrophages and osteoblasts by titanium-based particles.
Biomaterials. 2008;29(15):2326–35.
34. Rodrigo A, Vallés G, Saldaña L, Rodríguez M, Martínez ME, Munuera L,
Vilaboa N. Alumina particles influence the interactions of cocultured
osteoblasts and macrophages. J Orthop Res. 2006;24(1):46–54.
35. Li G, Wu P, Xu Y, Yu Y, Sun L, Zhu L, Ye D. The effect of Lipoxin A4 on the
interaction between macrophage and osteoblast: possible role in the
treatment of aseptic loosening. BMC Musculoskelet Disord. 2009;10:57.
36. Evans CE. Bisphosphonates modulate the effect of macrophage-like cells on
osteoblast. Int J Biochem Cell Biol. 2002;34(5):554–63.
37. Flores ME, Norgard M, Heinegard D, Reinholt FP, Andersson G. RGD-directed
attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein,
and fibronectin. Exp Cell Res. 1992;201(2):526–30.
38. Tezuka K, Sato T, Kamioka H, Nijweide PJ, Tanaka K, Matsuo T, Ohta M,
Kurihara N, Hakeda Y, Kumegawa M. Identification of osteopontin in isolated
rabbit osteoclasts. Biochem Biophys Res Commun. 1992;186(2):911–7.
39. Chen J, Singh K, Mukherjee BB, Sodek J. Developmental expression of
osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone
formation and resorption. Matrix. 1993;13(2):113–23.
40. Aubin JE. Regulation of osteoblast formation and function. Rev Endocr
Metab Disord. 2001;2(1):81–94.
41. Weinreb M, Shinar D, Rodan GA. Different pattern of alkaline phosphatase,
osteopontin, and osteocalcin expression in developing rat bone visualized
by in situ hybridization. J Bone Miner Res. 1990;5(8):831–42.
42. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM.
Osteopontin is elevated during neointima formation in rat arteries and is a
novel component of human atherosclerotic plaques. J Clin Invest. 1993;
92(4):1686–96.
43. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J.
1993;7(15):1475–82.
44. Denhardt DT, Noda M, O’Regan AW, Pavlin D, Berman JS. Osteopontin as a
means to cope with environmental insults: regulation of inflammation,
tissue remodeling, and cell survival. J Clin Invest. 2001;107(9):1055–61.
45. Gravallese EM. Osteopontin: a bridge between bone and the immune
system. J Clin Invest. 2003;112(2):147–9.
46. Shimizu S, Okuda N, Kato N, Rittling SR, Okawa A, Shinomiya K, Muneta T,
Denhardt DT, Noda M, Tsuji K et al. Osteopontin deficiency impairs
wear debris-induced osteolysis via regulation of cytokine secretion from
murine macrophages. Arthritis Rheum. 2010;62(5):1329–37.
47. Kuczkowski J, Sakowicz-Burkiewicz M, Izycka-Swieszewska E, Mikaszewski B,
Pawelczyk T. Expression of tumor necrosis factor-alpha, interleukin-1alpha,
interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
ORL J Otorhinolaryngol Relat Spec. 2011;73(2):93–9.
48. Lee SS, Sharma AR, Choi BS, Jung JS, Chang JD, Park S, Salvati EA, Purdue
EP, Song DK, Nam JS. The effect of TNFalpha secreted from macrophages
activated by titanium particles on osteogenic activity regulated by WNT/
BMP signaling in osteoprogenitor cells. Biomaterials. 2012;33(17):4251–63.
49. Kim J, Hematti P. Mesenchymal stem cell–educated macrophages: A novel
type of alternatively activated macrophages. Exp Hematol. 2009;37(12):
1445–53.
50. Spano A, Barni S, Sciola L. PMA withdrawal in PMA-treated monocytic THP-1
cells and subsequent retinoic acid stimulation, modulate induction of
apoptosis and appearance of dendritic cells. Cell Prolif. 2013;46(3):328–47.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Jablonski et al. BMC Musculoskeletal Disorders  (2016) 17:199 Page 12 of 12
